Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.6.2 to v3.6.3. This update reflects a standard versioning change rather than substantive changes to the study page.SummaryDifference0.1%

- Check7 days agoChange DetectedThe page's revision tag has been updated from v3.6.0 to v3.6.2, reflecting a deployment update. This change updates the page version reference without altering the study information visible to users.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record now indicates that recruitment is closed, reflecting that no more participants are being sought. New user-help sections were added, the intervention header got a formatting update, and the page shows a new revision tag (v3.6.0).SummaryDifference0.5%

- Check29 days agoChange DetectedThe page now displays a new release identifier, Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects an update to the page's versioning rather than a change to the study details or user interactions.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 in the page footer, indicating a new build. This metadata change does not modify study content, results, or eligibility information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor update to the study record. This change does not affect the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.